Viliam Lustig

715 total citations
26 papers, 533 citations indexed

About

Viliam Lustig is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Viliam Lustig has authored 26 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Viliam Lustig's work include Acute Myocardial Infarction Research (9 papers), Biochemical and Molecular Research (6 papers) and Alkaline Phosphatase Research Studies (5 papers). Viliam Lustig is often cited by papers focused on Acute Myocardial Infarction Research (9 papers), Biochemical and Molecular Research (6 papers) and Alkaline Phosphatase Research Studies (5 papers). Viliam Lustig collaborates with scholars based in Canada and United States. Viliam Lustig's co-authors include Glenn E. Palomaki, Andrew R. MacRae, Peter A. Kavsak, Allan S. Jaffe, Dennis T. Ko, Alice Newman, Rakesh Bhargava, Jack V. Tu, John A. Kellen and Robert L. Patten and has published in prestigious journals such as Clinical Chemistry, American Heart Journal and Clinica Chimica Acta.

In The Last Decade

Viliam Lustig

24 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viliam Lustig Canada 11 372 193 102 76 60 26 533
Franca Pagani Italy 17 583 1.6× 270 1.4× 181 1.8× 60 0.8× 77 1.3× 28 865
Pennell C. Painter United States 8 382 1.0× 174 0.9× 119 1.2× 68 0.9× 61 1.0× 11 780
Ana Pastor Spain 6 425 1.1× 325 1.7× 125 1.2× 110 1.4× 46 0.8× 11 768
Eduardo Perna Argentina 14 606 1.6× 120 0.6× 144 1.4× 74 1.0× 45 0.8× 59 753
Silvia Masotti Italy 18 561 1.5× 149 0.8× 122 1.2× 52 0.7× 133 2.2× 46 830
Yücel Balbay Türkiye 17 388 1.0× 101 0.5× 261 2.6× 113 1.5× 29 0.5× 43 616
R Richter Germany 8 368 1.0× 43 0.2× 163 1.6× 100 1.3× 28 0.5× 23 564
Mary Lou Gantzer United States 10 204 0.5× 59 0.3× 89 0.9× 22 0.3× 90 1.5× 14 538
Michael N. Zairis Greece 18 552 1.5× 98 0.5× 283 2.8× 197 2.6× 76 1.3× 35 853
Show Hong Duh United States 7 231 0.6× 132 0.7× 65 0.6× 25 0.3× 38 0.6× 9 368

Countries citing papers authored by Viliam Lustig

Since Specialization
Citations

This map shows the geographic impact of Viliam Lustig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viliam Lustig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viliam Lustig more than expected).

Fields of papers citing papers by Viliam Lustig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viliam Lustig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viliam Lustig. The network helps show where Viliam Lustig may publish in the future.

Co-authorship network of co-authors of Viliam Lustig

This figure shows the co-authorship network connecting the top 25 collaborators of Viliam Lustig. A scholar is included among the top collaborators of Viliam Lustig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viliam Lustig. Viliam Lustig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kavsak, Peter A., Dennis T. Ko, Alice Newman, et al.. (2007). “Upstream markers” provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. Clinica Chimica Acta. 387(1-2). 133–138. 10 indexed citations
2.
Kavsak, Peter A., Dennis T. Ko, Alice Newman, et al.. (2007). Vascular versus myocardial dysfunction in acute coronary syndrome: Are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?. Clinical Biochemistry. 41(6). 436–439. 4 indexed citations
3.
Kavsak, Peter A., Andrew R. MacRae, Alice Newman, et al.. (2007). Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clinica Chimica Acta. 380(1-2). 213–216. 44 indexed citations
4.
Kavsak, Peter A., Andrew R. MacRae, Alice Newman, et al.. (2007). Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clinical Biochemistry. 40(5-6). 326–329. 50 indexed citations
5.
Kavsak, Peter A., Andrew R. MacRae, Viliam Lustig, et al.. (2006). The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. American Heart Journal. 152(1). 118–125. 60 indexed citations
6.
MacRae, Andrew R., Peter A. Kavsak, Viliam Lustig, et al.. (2006). Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clinical Chemistry. 52(5). 812–818. 139 indexed citations
7.
Kavsak, Peter A., Andrew R. MacRae, Glenn E. Palomaki, et al.. (2006). Health Outcomes Categorized by Current and Previous Definitions of Acute Myocardial Infarction in an Unselected Cohort of Troponin-Naive Emergency Department Patients. Clinical Chemistry. 52(11). 2028–2035. 16 indexed citations
8.
9.
10.
Lustig, Viliam, et al.. (1980). Improved serum-initiated aspartate aminotransferase assay by inhibition of lactate dehydrogenase with oxamate.. Clinical Chemistry. 26(7). 831–834. 6 indexed citations
11.
Lustig, Viliam, et al.. (1980). Improved serum-initiated aspartate aminotransferase assay by inhibition of lactate dehydrogenase with oxamate.. Clinical Chemistry. 26(7). 831–834. 7 indexed citations
12.
Lustig, Viliam, et al.. (1979). Improved serum initiated aspartate aminotransferase assay by inhibition of lactate dehydrogenase with oxamate. Clinical Biochemistry. 12(6). 254–255. 1 indexed citations
13.
Lustig, Viliam & Robert L. Patten. (1976). Activation of aspartate transaminase by pyridoxal 5′-phosphate in the serum of normal subjects. Clinica Chimica Acta. 69(1). 101–103. 16 indexed citations
14.
Lustig, Viliam. (1974). Enzymatic Determination of Inorganic Phosphate in Serum and Urine with a Centrifugal Analyzer. Clinical Chemistry. 20(10). 1381–1381. 2 indexed citations
15.
Lustig, Viliam & John A. Kellen. (1973). Fructose-1,6-Diphosphatase in DMBA-induced Rat Mammary Tumours. Oncology. 27(3). 266–280.
16.
Lustig, Viliam & John A. Kellen. (1972). Fructose 1,6-diphosphate activity in rat mammary glands. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 42(4). 703–711.
17.
Kellen, John A. & Viliam Lustig. (1971). Patterns of Amino-acid Inhibition of Alkaline Phosphatases as an Aid in Cancer Diagnosis. Oncology. 25(3). 239–248. 4 indexed citations
18.
Lustig, Viliam & John A. Kellen. (1971). Species, organ and subcellular specificity of alkaline phosphatases as determined by amino acid inhibition studies. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 39(2). 305–310. 6 indexed citations
19.
Lustig, Viliam & John A. Kellen. (1971). Effects of L-homoarginine on rat tissue alkaline phosphatases in vivo.. PubMed. 41(6). 336–44. 3 indexed citations
20.
Lustig, Viliam & John A. Kellen. (1971). Temperature optimum of alkaline phosphatases in some homeothermic and poikilothermic species. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 39(2). 311–315. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franca Pagani Breakdown of academic impact, for papers by Pennell C. Painter Breakdown of academic impact, for papers by Ana Pastor Breakdown of academic impact, for papers by Eduardo Perna Breakdown of academic impact, for papers by Silvia Masotti Breakdown of academic impact, for papers by Yücel Balbay Breakdown of academic impact, for papers by R Richter Breakdown of academic impact, for papers by Mary Lou Gantzer Breakdown of academic impact, for papers by Michael N. Zairis Breakdown of academic impact, for papers by Show Hong Duh
Rankless by CCL
2026